Evaluation in 18 patients with polycythemia vera showed hematocrit control below 45%, accompanied by a "dramatic decrease in ...

The phase 2 SANRECO study has recently completed enrollment and will evaluate divesiran, a potential therapy for patients ...

CURE spoke with Dr. Marina Kremyanskaya about the treatment landscape for patients with polycythemia vera.

Marissa Johanna Maria Traets Bridging Pathophysiology and Therapeutic Targets in Sickle Cell Disease dr. M.A.E. Rab ...

A therapeutic intervention is an effort to help someone in need who declines treatment or is otherwise unable to help themselves. In some cases, an intervention takes the form of a meeting between the ...